These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30709448)

  • 1. Update on Myogenic Sarcomas.
    Agaram NP
    Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving classification of rhabdomyosarcoma.
    Agaram NP
    Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
    Dehner CA; Rudzinski ER; Davis JL
    Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas.
    Wesche WA; Fletcher CD; Dias P; Houghton PJ; Parham DM
    Am J Surg Pathol; 1995 Mar; 19(3):261-9. PubMed ID: 7872424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric nonrhabdomyosarcoma soft tissue sarcomas: progress on clinical and biologic fronts.
    Wexler LH; Garvin JH
    J Pediatr; 1997 Oct; 131(4):508-9. PubMed ID: 9386647
    [No Abstract]   [Full Text] [Related]  

  • 8. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature.
    Vadgama B; Sebire NJ; Malone M; Ramsay AD
    Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
    Mentzel T
    Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
    Parham DM; Giannikopoulos P
    Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic Sarcomas: The State of the Art.
    Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
    Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
    Kohashi K; Kinoshita I; Oda Y
    Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
    Harms D
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
    Tallini G; Parham DM; Dias P; Cordon-Cardo C; Houghton PJ; Rosai J
    Am J Pathol; 1994 Apr; 144(4):693-701. PubMed ID: 8160771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.
    Parham DM
    Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
    Furlong MA; Fanburg-Smith JC
    Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.
    Dias P; Parham DM; Shapiro DN; Webber BL; Houghton PJ
    Am J Pathol; 1990 Dec; 137(6):1283-91. PubMed ID: 2260621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.